Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease (Q34510415)

2 August 2017

1 reference

title

Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease (English)

1 reference

2 August 2017

1 reference

1 reference

Thobois S

1

1 reference

PubMed ID

11817273

2 August 2017

Guillouet S

series ordinal

2

1 reference

PubMed ID

11817273

2 August 2017

Broussolle E

series ordinal

3

1 reference

2 August 2017

1 October 2001

1 reference

Neurophysiologie Clinique

2 August 2017

1 reference

2 August 2017

31

1 reference

2 August 2017

5

1 reference

2 August 2017

321-340

1 reference

Functional architecture of basal ganglia circuits: neural substrates of parallel processing

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Effect of age on D2 dopamine receptors in normal human brain measured by positron emission tomography and 11C-raclopride.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

[123I]beta-CIT and SPECT in essential tremor and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Dopa-responsive dystonia: A clinical and molecular genetic study

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

[3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

PET studies in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

The early diagnosis of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Isolated tremor and disruption of the nigrostriatal dopaminergic system: An 18F-dopa PET study

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Relief of akinesia by apomorphine and cerebral metabolic changes in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

[18 F]-dopa PET study in patients with juvenile-onset PD and parkin gene mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Striatal dopamine D2-receptor blockade by typical and atypical neuroleptics.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

D2 receptor blockade by flunarizine and cinnarizine explains extrapyramidal side effects. A SPECT study.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Nigral dysfunction in drug-induced parkinsonism: an 18F-dopa PET study.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Preliminary report: activation of the cerebellum in essential tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Age-dependent decline of nigrostriatal dopaminergic function: a positron emission tomographic study of grandparents and their grandchildren

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Subcortical dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

The neurophysiological basis of motor imagery

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Thalamic stimulation and suppression of parkinsonian tremor. Evidence of a cerebellar deactivation using positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Striatal D2 dopamine receptor status in Parkinson's disease: an [18F]dopa and [11C]raclopride PET study

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Motor imagery of a lateralized sequential task is asymmetrically slowed in hemi-Parkinson's patients

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Cognitive deficits in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

The metabolic topography of parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Striatal 18F-dopa uptake: absence of an aging effect

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Dopamine autoreceptor function is lost in advanced Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Synthesis and ligand binding of nortropane derivatives: N-substituted 2beta-carbomethoxy-3beta-(4'-iodophenyl)nortropane and N-(3-iodoprop-(2E)-enyl)-2beta-carbomethoxy-3beta-(3',4'-disubstituted phenyl)nortropane. New high-affinity and selective co

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Striatonigral degeneration. A clinicopathological study.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Updating the functional model of the basal ganglia.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Corticobasal Degeneration: Neuropsychological Assessment and Dopamine D 2 Receptor SPECT Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Association between essential tremor and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Corticobasal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Effect of reserpine-induced depletion of synaptic dopamine on [11C]raclopride binding to D2-dopamine receptors in the monkey brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Magnetic resonance imaging of corticobasal degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

A selective radiobrominated cocaine analogue for imaging of dopamine uptake sites: pharmacological evaluation and PET experiments.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Parkinsonism: onset, progression, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Functional effects of striatal dysfunction in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

PET imaging of the dopamine transporter in progressive supranuclear palsy and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Self-initiated versus externally triggered movements

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Evidence for striatal dopamine release during a video game.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Tremors in Early Parkinsonʼs Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Pharmacokinetics and dosimetry of iodine-123 labelled PE2I in humans, a radioligand for dopamine transporter imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Parkinson's disease. First of two parts

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Parkinson's disease. Second of two parts

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

The definition of multiple system atrophy: a review of recent developments

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Cellular pathology of multiple system atrophy: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Fluorodopa uptake and glucose metabolism in early stages of corticobasal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Steele-Richardson-Olszewski syndrome. Brain energy metabolism, blood flow and fluorodopa uptake measured by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

The effects of L-DOPA on regional cerebral blood flow and oxygen metabolism in patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

A point mutation in the tyrosine hydroxylase gene associated with Segawa's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Contribution of PET studies in diagnosis of corticobasal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Differential distribution of striatal [123I]beta-CIT in Parkinson's disease and progressive supranuclear palsy, evaluated with single-photon emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Levodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease. Lack of correlation with clinical or neuropsychological improvements

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Evidence for a common network of brain structures involved in parkinsonian tremor and voluntary repetitive movement.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Dopamine D1 and D2 receptors in progressive supranuclear palsy: an autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Dopaminergic function in familial Parkinson's disease: A clinical and18F-dopa positron emission tomography study

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Multiple system atrophy--the nature of the beast

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Dopa-responsive dystonia: pathological and biochemical observations in a case.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Clinicopathologic observations in essential tremor: report of six cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

The ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Corticodentatonigral Degeneration With Neuronal Achromasia

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Clinical correlates of [18F]fluorodopa uptake in five grafted parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Cortical-basal ganglionic degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Motor dysfunction in olivopontocerebellar atrophy is related to cerebral metabolic rate studied with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Subcutaneous apomorphine increases regional cerebral blood flow in parkinsonian patients via peripheral mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

PET studies of parkinsonism associated with mutation in the alpha-synuclein gene

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements. A PET study.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Pallidotomy in Parkinson's disease increases supplementary motor area and prefrontal activation during performance of volitional movements an H2(15)O PET study.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

SPECT findings in Parkinson's disease associated with dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Striatal function in normal aging: implications for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Dopa-responsive dystonia: [18F]dopa positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

123I-iodobenzamide-SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Dopamine D1 receptors in Parkinson's disease and striatonigral degeneration: a positron emission tomography study

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Overactivation of primary motor cortex is asymmetrical in hemiparkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Motor imagery in normal subjects and in asymmetrical Parkinson's disease: a PET study

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Differential effects of levodopa on dopaminergic function in early and advanced Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

In vivo studies on striatal dopamine D1 and D2 site binding in L-dopa-treated Parkinson's disease patients with and without dyskinesias.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Clinical features and natural history of multiple system atrophy. An analysis of 100 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Effects of Age on Dopamine and Serotonin Receptors Measured by Positron Tomography in the Living Human Brain

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

In vivo measurement of dopamine receptors in human brain by positron emission tomography. Age and sex differences

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0987-7053%2801%2900273-8

7 January 2021

10.1016/S0987-7053(01)00273-8

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11817273